An international team led by Monash University researchers has uncovered the genetic code governing the way genetic mutations ...

Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...

In a city, coworking hubs bring people and ideas together. Inside cancer cells, similar hubs form—but instead of fueling ...

ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA therapeutics, announced today that it will present initial Phase 1 clinical data for ADX ...

ProQR ( ($PRQR) ) has shared an announcement. On October 20, 2025, ProQR Therapeutics announced that it received Clinical Trial Application (CTA) ...

Researchers at the Centre for Genomic Regulation show that cancer doesn’t invent new tricks—it reawakens embryonic splicing ...

Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, has opened a unique perfusion 'Liver ICU' lab in the Alexandria Centre for Life Sciences.

The federal government has been—and must remain—a critical partner in foundational technological innovation and research ...

Lung cancer and melanoma patients immunized with this formula doubled their chances of surviving three years, according to a ...

The event will take place on November 3, 2025 beginning at 10 am ET and will feature presentations by ProQR Management and Key Opinion Leader Professor Henkjan J. Verkade, MD, PhD, a pediatric ...

Astrophysicists from Keele University, alongside an international research team supported by NASA, detected large complex ...

The breakthrough mRNA vaccine that enabled the world to fight Covid-19 may also be used to fight cancers of the lung or skin.